Genomic Characterization of Carbapenemase-Producing , , , , and Clinical Isolates from Bulgaria.

Carbapenemase-producing spp. , , spp., and (CP-ESCPM) are increasingly identified as causative agents of nosocomial infections but are still not under systematic genomic surveillance. In this study, using a combination of whole-genome sequencing and conjugation experiments, we sought to elucidate the genomic characteristics and transferability of resistance genes in clinical CP-ESCPM isolates from Bulgaria. Among the 36 sequenced isolates, NDM-1 (12/36), VIM-4 (11/36), VIM-86 (8/36), and OXA-48 (7/36) carbapenemases were identified; two isolates carried both NDM-1 and VIM-86. The majority of carbapenemase genes were found on self-conjugative plasmids. IncL plasmids were responsible for the spread of OXA-48 among , , and . IncM2 plasmids were generally associated with the spread of NDM-1 in and , and also of VIM-4 in . IncC plasmids were involved in the spread of the recently described VIM-86 in isolates. IncC plasmids carrying and were observed too. was also detected on IncX3 in and on IncT plasmid in . The significant resistance transfer rates we observed highlight the role of the ESCPM group as a reservoir of resistance determinants and stress the need for strengthening infection control measures.